DraftKings downgraded, AMD upgraded: Wall Street's top analyst calls The Fly Mon, November 9, 2026 at 9:35 AM EST 3 min read SBUX +2.16% EBAY +1.00% ETN +3.92% GLW +6.59% ABNB +2.53% Explore stocks on Coinbase Trading disclosure Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.Top 5 Upgrades:
Oppenheimer upgraded AMD (AMD) to Outperform from Perform with a $600 price target after the company reported another bullish earnings report.
Rothschild & Co Redburn upgraded Airbnb (ABNB) to Neutral from Sell with a price target of $190, up from $135. The firm says it failed to notice earlier this year that Airbnb's efforts "behind the scenes had laid the groundwork for an acceleration in the core business."
JPMorgan upgraded Tronox (TROX) to Neutral from Underweight without a price target. The firm cites valuation for the upgrade but says Tronox's business conditions remains "uncertain and negative."
Jefferies upgraded TripAdvisor (TRIP) to Hold from Underperform with a price target of $7, down from $8. Jefferies says TripAdvisor's "peer-low" valuation and potential catalysts from ramping activist investor involvement create a more balanced risk/reward at current share levels.
JPMorgan upgraded Unum Group (UNM) to Overweight from Neutral with a price target of $90, down from $98. The firm says Unum's risk/reward is now attractive, even on lowered estimates, as stable employment and wage trends should be supportive of the business.
JPMorgan downgraded DraftKings (DKNG) to Neutral from Overweight with a price target of $21, down from $30, and removed the stock from its Analyst Focus List. Following the Q3 report, the firm has little conviction in DraftKings' fiscal 2027 and 2028 EBITDA. UBS and Stifel also downgraded DraftKings to Neutral-equivalent ratings.
KeyBanc downgraded Zillow Group (ZG) to Sector Weight from Overweight without a price target. The firm cites the company's weaker than expected Q3 results and "significant reset to the forward outlook" for the downgrade.
Aletheia downgraded Nvidia (NVDA) to Hold from Buy without a price target. The firm cites risks associated with Nvidia's new AI computing partner program and "potential turmoil at the company" amid the investigation into its CEO for the downgrade.
Rothschild & Co Redburn downgraded TransUnion (TRU) to Neutral from Buy with a price target of $91, up from $89. The firm remains positive on TransUnion's longer-term opportunity for growth and margin expansion, but says the company's Q3 report left it with some near-term concerns.
JPMorgan downgraded Molson Coors (TAP) to Underweight from Neutral with a price target of $37, down from $41, following the Q3 report. The firm says ongoing softness in the U.S. beer category, competitive environment in the U.K., and incremental cost pressures outpacing cost savings led to a steep guidance cut "that paints a tough picture into 2027.
Stifel resumed coverage of Starbucks (SBUX) with a Buy rating and $115 price target. The firm, which estimates FY27 global same-store sales growth of 4% with similar contribution from North American and International growth, believes Starbucks' earnings recovery is becoming increasingly self-funding as sales leverage and cost savings help offset investments in labor and the coffeehouse experience.
Citi resumed coverage of Uber (UBER) with a Buy rating and $105 price target. The firm is "incrementally positive" on the shares following the Q3 report and meetings with management.
Citi resumed coverage of L3Harris Technologies (LHX) with a Buy rating and $348 price target following a period of suspension. The company is "uniquely well-exposed" to defense "megatrends," including munition replenishment, space, and international rearmament, the analyst tells investors in a research note.
H.C. Wainwright assumed coverage of United Therapeutics (UTHR) with a Buy rating and $660 price target. The firm says the company has evolved into a multi-route pulmonary hypertension platform.
William Blair initiated coverage of Graham (GHM) with an Outperform rating and fair value estimate of $101. Graham is evolving from a defense-oriented engineering manufacturer to a diversified supplier of mission-critical technologies across multiple markets, the firm tells investors in a research note.
